85,754 Shares in Ardent Health Partners, LLC (NYSE:ARDT) Bought by Oliver Luxxe Assets LLC

Oliver Luxxe Assets LLC purchased a new position in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 85,754 shares of the company's stock, valued at approximately $1,465,000. Oliver Luxxe Assets LLC owned about 0.06% of Ardent Health Partners at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Wellington Management Group LLP bought a new stake in Ardent Health Partners in the 3rd quarter worth approximately $28,724,000. Point72 Asset Management L.P. bought a new stake in shares of Ardent Health Partners in the third quarter worth $27,428,000. Goldentree Asset Management LP purchased a new stake in Ardent Health Partners during the third quarter valued at $22,897,000. Franklin Resources Inc. bought a new position in Ardent Health Partners in the third quarter valued at about $15,839,000. Finally, Allspring Global Investments Holdings LLC purchased a new position in Ardent Health Partners in the third quarter worth about $13,119,000.

Ardent Health Partners Stock Down 5.4 %

ARDT traded down $0.82 on Friday, hitting $14.43. 266,897 shares of the company's stock traded hands, compared to its average volume of 387,820. Ardent Health Partners, LLC has a one year low of $13.63 and a one year high of $20.72. The firm has a 50 day simple moving average of $16.11. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.29 by ($0.10). The company had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.46 billion. Research analysts expect that Ardent Health Partners, LLC will post 1.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Morgan Stanley lowered their price objective on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday. Bank of America downgraded shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Leerink Partners upped their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 12th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, KeyCorp assumed coverage on Ardent Health Partners in a report on Friday, October 11th. They set an "overweight" rating and a $24.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Ardent Health Partners presently has an average rating of "Buy" and a consensus target price of $21.55.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.